Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

Published:2018-10 Issue:4 Volume:142 Page:1121-1130.e7
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Kabashima Kenji,Furue Masutaka,Hanifin Jon M.,Pulka Grazyna,Wollenberg Andreas,Galus Ryszard,Etoh Takafumi,Mihara Ryosuke,Nakano Miwa,Ruzicka Thomas

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients;Wollenberg;J Eur Acad Dermatol Venereol,2016

2. Multifactorial skin barrier deficiency and atopic dermatitis: essential topics to prevent the atopic march;Egawa;J Allergy Clin Immunol,2016

3. Advances in atopic dermatitis in 2015;Nomura;J Allergy Clin Immunol,2016

4. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis;Werfel;J Allergy Clin Immunol,2016

5. Quality of health care of atopic eczema in Germany: results of the national health care study atopic health;Langenbruch;J Eur Acad Dermatol Venereol,2014

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Biologics for Atopic Dermatitis;Immunology and Allergy Clinics of North America;2024-09

2. The role of nemolizumab in the treatment of atopic dermatitis for the adult population;Immunotherapy;2024-08-09

3. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials;The Lancet;2024-08

4. Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations;Journal of Allergy and Clinical Immunology;2024-07

5. Monoclonal Antibodies: Current Advancements and Future Potential for Atopic Dermatitis Therapy;Current Pharmaceutical Biotechnology;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3